Optimizing use of multi-antibody assays for Lyme disease diagnosis: A bioinformatic approach.
Multiple different recombinant and peptide antigens are now available for serodiagnosis of Lyme disease (LD), but optimizing test utilization remains challenging. Since 1995 the Centers for Disease Control and Prevention (CDC) has recommended a 2-tiered serologic approach consisting of a first-tier...
Guardado en:
Autores principales: | Richard Porwancher, Lisa Landsberg |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/75ac4a0f062f493f9a23a39e4c34413c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Increasing of informational content of serological diagnosis of acute Lyme- borreliosis
por: M.I. Shkilna, et al.
Publicado: (2020) -
Discovery of the Lyme Disease Agent
por: Alan G. Barbour, et al.
Publicado: (2019) -
Suicide and Lyme and associated diseases
por: Bransfield RC
Publicado: (2017) -
Aggressiveness, violence, homicidality, homicide, and Lyme disease
por: Bransfield RC
Publicado: (2018) -
Contrasting emergence of Lyme disease across ecosystems
por: Atle Mysterud, et al.
Publicado: (2016)